These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28218868)
1. [Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 15 October 2016]. Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B Orv Hetil; 2017 Feb; 158(Suppl 1):23-35. PubMed ID: 28218868 [TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline]. Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 22 September 2017]. Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B Orv Hetil; 2018 Feb; 159(Suppl 1):24-37. PubMed ID: 29478340 [TBL] [Abstract][Full Text] [Related]
4. [Not Available]. Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B Orv Hetil; 2015 Dec; 156 Suppl 2():25-36. PubMed ID: 26667112 [TBL] [Abstract][Full Text] [Related]
5. [Not Available]. Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Hunyady B Orv Hetil; 2015 Mar; 156 Suppl 1():25-35. PubMed ID: 26039414 [TBL] [Abstract][Full Text] [Related]
6. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis]. Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline]. Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886 [TBL] [Abstract][Full Text] [Related]
9. [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017]. Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Péter Z; Rókusz L; Schneider F; Szalay F; Tornai I; Werling K; Makara M Orv Hetil; 2018 Feb; 159(Suppl 1):3-23. PubMed ID: 29478339 [TBL] [Abstract][Full Text] [Related]
10. [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016]. Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Péter Z; Rókusz L; Schneider F; Szalay F; Tornai I; Werling K; Makara M Orv Hetil; 2017 Feb; 158(Suppl 1):3-22. PubMed ID: 28218867 [TBL] [Abstract][Full Text] [Related]
11. [Interdisciplinary aspects of and new drugs for chronic hepatitis B]. Horváth G Orv Hetil; 2013 Jul; 154(29):1142-50. PubMed ID: 23853347 [TBL] [Abstract][Full Text] [Related]
12. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis. Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701 [TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B: Evolution over two decades. Yuen MF; Lai CL J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525 [TBL] [Abstract][Full Text] [Related]
14. Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Kanwal F; Gralnek IM; Martin P; Dulai GS; Farid M; Spiegel BM Ann Intern Med; 2005 May; 142(10):821-31. PubMed ID: 15897532 [TBL] [Abstract][Full Text] [Related]
15. Chronic Hepatitis B Infection: A Review. Tang LSY; Covert E; Wilson E; Kottilil S JAMA; 2018 May; 319(17):1802-1813. PubMed ID: 29715359 [TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Chan HL; Leung NW; Hui AY; Wong VW; Liew CT; Chim AM; Chan FK; Hung LC; Lee YT; Tam JS; Lam CW; Sung JJ Ann Intern Med; 2005 Feb; 142(4):240-50. PubMed ID: 15710957 [TBL] [Abstract][Full Text] [Related]
17. Clinical potential of emerging new agents in hepatitis B. Farrell GC Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196 [TBL] [Abstract][Full Text] [Related]
18. Taiwan consensus statement on the management of chronic hepatitis B. Chien RN; Kao JH; Peng CY; Chen CH; Liu CJ; Huang YH; Hu TH; Yang HI; Lu SN; Ni YH; Chuang WL; Lee CM; Wu JC; Chen PJ; Liaw YF J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):7-38. PubMed ID: 30527436 [TBL] [Abstract][Full Text] [Related]